COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:COVH • FR0000060303

23.3 EUR
0 (0%)
Last: Feb 10, 2026, 12:15 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

COVH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. COVH has an average financial health and profitability rating. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • COVH had positive earnings in the past year.
  • In the past year COVH had a positive cash flow from operations.
  • In multiple years COVH reported negative net income over the last 5 years.
  • In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.88%, COVH is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
  • COVH has a better Return On Equity (5.87%) than 64.29% of its industry peers.
  • COVH has a Return On Invested Capital of 3.67%. This is comparable to the rest of the industry: COVH outperforms 59.52% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for COVH is in line with the industry average of 3.45%.
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROIC 3.67%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • COVH has a Profit Margin of 78.86%. This is amongst the best in the industry. COVH outperforms 88.10% of its industry peers.
  • COVH's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 101.41%, COVH belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.41%
PM (TTM) 78.86%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
  • COVH has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, COVH has more shares outstanding
  • Compared to 1 year ago, COVH has a worse debt to assets ratio.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.03, we must say that COVH is in the distress zone and has some risk of bankruptcy.
  • COVH has a better Altman-Z score (1.03) than 69.05% of its industry peers.
  • COVH has a debt to FCF ratio of 12.71. This is a negative value and a sign of low solvency as COVH would need 12.71 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 12.71, COVH perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
  • A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
  • COVH's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. COVH outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.03
ROIC/WACC0.68
WACC5.42%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH has a better Current ratio (1.16) than 85.71% of its industry peers.
  • COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
  • COVH has a Quick ratio of 1.16. This is amongst the best in the industry. COVH outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 242.64% over the past year.
  • The earnings per share for COVH have been decreasing by -12.16% on average. This is quite bad
  • The Revenue has decreased by -5.26% in the past year.
  • Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

  • COVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.
  • Based on estimates for the next years, COVH will show a small growth in Revenue. The Revenue will grow by 0.55% on average per year.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.88, the valuation of COVH can be described as correct.
  • COVH's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of COVH to the average of the S&P500 Index (28.03), we can say COVH is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 13.52, which indicates a correct valuation of COVH.
  • COVH's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of COVH to the average of the S&P500 Index (27.97), we can say COVH is valued rather cheaply.
Industry RankSector Rank
PE 16.88
Fwd PE 13.52
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • COVH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COVH is cheaper than 64.29% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, COVH is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 17.03
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.61
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • COVH has a Yearly Dividend Yield of 6.47%, which is a nice return.
  • COVH's Dividend Yield is a higher than the industry average which is at 5.29.
  • COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 6.47%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • COVH pays out 19.17% of its income as dividend. This is a sustainable payout ratio.
DP19.17%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVIVIO HOTELS SACA

EPA:COVH (2/10/2026, 12:15:02 PM)

23.3

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22
Earnings (Next)02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.68B
Revenue(TTM)260.60M
Net Income(TTM)205.50M
Analysts82.86
Price Target18.67 (-19.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.47%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 13.52
P/S 14.13
P/FCF 15.91
P/OCF 10.06
P/B 1.05
P/tB 1.16
EV/EBITDA 17.03
EPS(TTM)1.38
EY5.92%
EPS(NY)1.72
Fwd EY7.4%
FCF(TTM)1.46
FCFY6.29%
OCF(TTM)2.32
OCFY9.94%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.61
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROCE 4.15%
ROIC 3.67%
ROICexc 4.06%
ROICexgc 4.3%
OM 101.41%
PM (TTM) 78.86%
GM N/A
FCFM 88.79%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.96
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.11
Cash Conversion 103.55%
Profit Quality 112.6%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.03
F-Score5
WACC5.42%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.66%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.4%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.44%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 16.88 and the Price/Book (PB) ratio is 1.05.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to grow by 3.01% in the next year.